nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP3A4—bone cancer	0.707	1	CbGaD
Pimozide—Ezetimibe—CYP3A4—bone cancer	0.00165	0.282	CrCbGaD
Pimozide—Astemizole—CYP3A4—bone cancer	0.00165	0.282	CrCbGaD
Pimozide—Sertindole—CYP3A4—bone cancer	0.00147	0.252	CrCbGaD
Pimozide—Loss of libido—Methotrexate—bone cancer	0.00144	0.0192	CcSEcCtD
Pimozide—Nuchal rigidity—Methotrexate—bone cancer	0.00128	0.0171	CcSEcCtD
Pimozide—Body temperature decreased—Epirubicin—bone cancer	0.00111	0.0148	CcSEcCtD
Pimozide—Hypothermia—Epirubicin—bone cancer	0.00111	0.0148	CcSEcCtD
Pimozide—Domperidone—CYP3A4—bone cancer	0.00107	0.184	CrCbGaD
Pimozide—Body temperature decreased—Doxorubicin—bone cancer	0.00103	0.0137	CcSEcCtD
Pimozide—Hypothermia—Doxorubicin—bone cancer	0.00103	0.0137	CcSEcCtD
Pimozide—Haemolytic anaemia—Cisplatin—bone cancer	0.000976	0.013	CcSEcCtD
Pimozide—Hyponatraemia—Cisplatin—bone cancer	0.000884	0.0118	CcSEcCtD
Pimozide—Orthostatic hypotension—Cisplatin—bone cancer	0.000804	0.0107	CcSEcCtD
Pimozide—Breast disorder—Cisplatin—bone cancer	0.000796	0.0106	CcSEcCtD
Pimozide—Cramp muscle—Cisplatin—bone cancer	0.000793	0.0105	CcSEcCtD
Pimozide—Speech disorder—Methotrexate—bone cancer	0.000774	0.0103	CcSEcCtD
Pimozide—Blood disorder—Epirubicin—bone cancer	0.000746	0.00992	CcSEcCtD
Pimozide—Abdominal discomfort—Cisplatin—bone cancer	0.00073	0.00971	CcSEcCtD
Pimozide—Pancytopenia—Cisplatin—bone cancer	0.000723	0.00962	CcSEcCtD
Pimozide—Amenorrhoea—Epirubicin—bone cancer	0.000709	0.00943	CcSEcCtD
Pimozide—Blood disorder—Doxorubicin—bone cancer	0.00069	0.00918	CcSEcCtD
Pimozide—Nocturia—Epirubicin—bone cancer	0.000672	0.00893	CcSEcCtD
Pimozide—Dyskinesia—Epirubicin—bone cancer	0.000663	0.00882	CcSEcCtD
Pimozide—Amenorrhoea—Doxorubicin—bone cancer	0.000656	0.00873	CcSEcCtD
Pimozide—Aplastic anaemia—Methotrexate—bone cancer	0.000625	0.00832	CcSEcCtD
Pimozide—Ventricular tachycardia—Epirubicin—bone cancer	0.000623	0.00829	CcSEcCtD
Pimozide—Nocturia—Doxorubicin—bone cancer	0.000622	0.00827	CcSEcCtD
Pimozide—Abnormal dreams—Epirubicin—bone cancer	0.000616	0.00819	CcSEcCtD
Pimozide—Dyskinesia—Doxorubicin—bone cancer	0.000614	0.00816	CcSEcCtD
Pimozide—Eructation—Epirubicin—bone cancer	0.000612	0.00814	CcSEcCtD
Pimozide—Salivary hypersecretion—Epirubicin—bone cancer	0.000605	0.00805	CcSEcCtD
Pimozide—Connective tissue disorder—Cisplatin—bone cancer	0.000599	0.00796	CcSEcCtD
Pimozide—Gynaecomastia—Methotrexate—bone cancer	0.000596	0.00792	CcSEcCtD
Pimozide—Visual impairment—Cisplatin—bone cancer	0.000587	0.00781	CcSEcCtD
Pimozide—Aplastic anaemia—Epirubicin—bone cancer	0.000585	0.00778	CcSEcCtD
Pimozide—Ventricular tachycardia—Doxorubicin—bone cancer	0.000577	0.00767	CcSEcCtD
Pimozide—Abnormal dreams—Doxorubicin—bone cancer	0.00057	0.00758	CcSEcCtD
Pimozide—Eye disorder—Cisplatin—bone cancer	0.000569	0.00757	CcSEcCtD
Pimozide—Eructation—Doxorubicin—bone cancer	0.000566	0.00753	CcSEcCtD
Pimozide—Cardiac disorder—Cisplatin—bone cancer	0.000566	0.00752	CcSEcCtD
Pimozide—Salivary hypersecretion—Doxorubicin—bone cancer	0.00056	0.00745	CcSEcCtD
Pimozide—Aplastic anaemia—Doxorubicin—bone cancer	0.000541	0.0072	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—bone cancer	0.00051	0.00678	CcSEcCtD
Pimozide—Muscle spasms—Cisplatin—bone cancer	0.00051	0.00678	CcSEcCtD
Pimozide—CALM1—trigeminal nerve—bone cancer	0.00051	0.141	CbGeAlD
Pimozide—Vision blurred—Cisplatin—bone cancer	0.0005	0.00665	CcSEcCtD
Pimozide—Tremor—Cisplatin—bone cancer	0.000497	0.00661	CcSEcCtD
Pimozide—Anaemia—Cisplatin—bone cancer	0.00049	0.00652	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—bone cancer	0.000481	0.0064	CcSEcCtD
Pimozide—Leukopenia—Cisplatin—bone cancer	0.000475	0.00632	CcSEcCtD
Pimozide—HRH1—nose—bone cancer	0.000474	0.131	CbGeAlD
Pimozide—Convulsion—Cisplatin—bone cancer	0.00046	0.00611	CcSEcCtD
Pimozide—Hyponatraemia—Epirubicin—bone cancer	0.000454	0.00604	CcSEcCtD
Pimozide—Myalgia—Cisplatin—bone cancer	0.000452	0.00601	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000448	0.00597	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—bone cancer	0.000445	0.00593	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—bone cancer	0.000437	0.00581	CcSEcCtD
Pimozide—Nervous system disorder—Cisplatin—bone cancer	0.000425	0.00565	CcSEcCtD
Pimozide—Tachycardia—Cisplatin—bone cancer	0.000423	0.00562	CcSEcCtD
Pimozide—Skin disorder—Cisplatin—bone cancer	0.00042	0.00559	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—bone cancer	0.00042	0.00559	CcSEcCtD
Pimozide—Hyperhidrosis—Cisplatin—bone cancer	0.000419	0.00557	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—bone cancer	0.000414	0.0055	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—bone cancer	0.000413	0.00549	CcSEcCtD
Pimozide—Anorexia—Cisplatin—bone cancer	0.000413	0.00549	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—bone cancer	0.000409	0.00544	CcSEcCtD
Pimozide—Hypotension—Cisplatin—bone cancer	0.000405	0.00538	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—bone cancer	0.0004	0.00533	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—bone cancer	0.000397	0.00528	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000394	0.00525	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—bone cancer	0.000391	0.0052	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—bone cancer	0.000387	0.00515	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—bone cancer	0.000385	0.00512	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—bone cancer	0.000382	0.00508	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—bone cancer	0.000378	0.00503	CcSEcCtD
Pimozide—Decreased appetite—Cisplatin—bone cancer	0.000376	0.00501	CcSEcCtD
Pimozide—Gastrointestinal disorder—Cisplatin—bone cancer	0.000374	0.00497	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—bone cancer	0.000372	0.00495	CcSEcCtD
Pimozide—Depression—Methotrexate—bone cancer	0.000371	0.00494	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—bone cancer	0.000371	0.00494	CcSEcCtD
Pimozide—CALM1—cranial nerve—bone cancer	0.000363	0.101	CbGeAlD
Pimozide—Dysphagia—Doxorubicin—bone cancer	0.000362	0.00481	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—bone cancer	0.000361	0.0048	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—bone cancer	0.000358	0.00476	CcSEcCtD
Pimozide—Sweating—Methotrexate—bone cancer	0.000357	0.00475	CcSEcCtD
Pimozide—Weight increased—Epirubicin—bone cancer	0.000356	0.00473	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—bone cancer	0.000354	0.0047	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—bone cancer	0.000349	0.00464	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—bone cancer	0.000348	0.00462	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—bone cancer	0.000344	0.00457	CcSEcCtD
Pimozide—Sweating—Epirubicin—bone cancer	0.000334	0.00444	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—bone cancer	0.000334	0.00444	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—bone cancer	0.000329	0.00438	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—bone cancer	0.000327	0.00435	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—bone cancer	0.000325	0.00433	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—bone cancer	0.000323	0.00429	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—bone cancer	0.000322	0.00429	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—bone cancer	0.000312	0.00416	CcSEcCtD
Pimozide—Asthenia—Cisplatin—bone cancer	0.000311	0.00413	CcSEcCtD
Pimozide—HTR2A—trigeminal nerve—bone cancer	0.000311	0.0861	CbGeAlD
Pimozide—Cardiac disorder—Methotrexate—bone cancer	0.00031	0.00413	CcSEcCtD
Pimozide—Sweating—Doxorubicin—bone cancer	0.000309	0.00411	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—bone cancer	0.000308	0.00409	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—bone cancer	0.000302	0.00401	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—bone cancer	0.000301	0.004	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—bone cancer	0.000296	0.00394	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—bone cancer	0.000293	0.0039	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—bone cancer	0.000292	0.00389	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—bone cancer	0.00029	0.00386	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—bone cancer	0.000285	0.00378	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—bone cancer	0.000279	0.00371	CcSEcCtD
Pimozide—Vomiting—Cisplatin—bone cancer	0.000275	0.00366	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—bone cancer	0.000274	0.00365	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—bone cancer	0.000274	0.00365	CcSEcCtD
Pimozide—Rash—Cisplatin—bone cancer	0.000273	0.00363	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—bone cancer	0.000273	0.00363	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—bone cancer	0.000271	0.0036	CcSEcCtD
Pimozide—Anaemia—Methotrexate—bone cancer	0.000269	0.00358	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—bone cancer	0.000269	0.00357	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—bone cancer	0.000262	0.00348	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—bone cancer	0.000261	0.00347	CcSEcCtD
Pimozide—Nausea—Cisplatin—bone cancer	0.000257	0.00342	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—bone cancer	0.000257	0.00341	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—bone cancer	0.000254	0.00337	CcSEcCtD
Pimozide—Convulsion—Methotrexate—bone cancer	0.000252	0.00335	CcSEcCtD
Pimozide—Anaemia—Epirubicin—bone cancer	0.000252	0.00335	CcSEcCtD
Pimozide—Agitation—Epirubicin—bone cancer	0.00025	0.00333	CcSEcCtD
Pimozide—Myalgia—Methotrexate—bone cancer	0.000248	0.0033	CcSEcCtD
Pimozide—Chest pain—Methotrexate—bone cancer	0.000248	0.0033	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000246	0.00327	CcSEcCtD
Pimozide—Syncope—Epirubicin—bone cancer	0.000244	0.00325	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—bone cancer	0.000244	0.00324	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—bone cancer	0.000242	0.00322	CcSEcCtD
Pimozide—Palpitations—Epirubicin—bone cancer	0.000241	0.0032	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—bone cancer	0.000239	0.00318	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—bone cancer	0.000238	0.00316	CcSEcCtD
Pimozide—Convulsion—Epirubicin—bone cancer	0.000236	0.00314	CcSEcCtD
Pimozide—Hypertension—Epirubicin—bone cancer	0.000235	0.00313	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—bone cancer	0.000233	0.0031	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—bone cancer	0.000233	0.0031	CcSEcCtD
Pimozide—Chest pain—Epirubicin—bone cancer	0.000232	0.00308	CcSEcCtD
Pimozide—Myalgia—Epirubicin—bone cancer	0.000232	0.00308	CcSEcCtD
Pimozide—Agitation—Doxorubicin—bone cancer	0.000232	0.00308	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—bone cancer	0.000231	0.00307	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00023	0.00306	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—bone cancer	0.00023	0.00305	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—bone cancer	0.000227	0.00302	CcSEcCtD
Pimozide—Anorexia—Methotrexate—bone cancer	0.000226	0.00301	CcSEcCtD
Pimozide—Syncope—Doxorubicin—bone cancer	0.000226	0.00301	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—bone cancer	0.000226	0.003	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—bone cancer	0.000223	0.00296	CcSEcCtD
Pimozide—Hypotension—Methotrexate—bone cancer	0.000222	0.00295	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—bone cancer	0.000222	0.00295	CcSEcCtD
Pimozide—HTR2A—cranial nerve—bone cancer	0.000221	0.0613	CbGeAlD
Pimozide—Shock—Epirubicin—bone cancer	0.000219	0.00291	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—bone cancer	0.000218	0.0029	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—bone cancer	0.000218	0.0029	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—bone cancer	0.000218	0.00289	CcSEcCtD
Pimozide—HTR2A—vertebral column—bone cancer	0.000217	0.0601	CbGeAlD
Pimozide—Tachycardia—Epirubicin—bone cancer	0.000217	0.00289	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000216	0.00288	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—bone cancer	0.000216	0.00287	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—bone cancer	0.000215	0.00286	CcSEcCtD
Pimozide—Insomnia—Methotrexate—bone cancer	0.000215	0.00286	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—bone cancer	0.000215	0.00285	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—bone cancer	0.000215	0.00285	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000213	0.00283	CcSEcCtD
Pimozide—Anorexia—Epirubicin—bone cancer	0.000212	0.00282	CcSEcCtD
Pimozide—Somnolence—Methotrexate—bone cancer	0.000211	0.00281	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—bone cancer	0.00021	0.00279	CcSEcCtD
Pimozide—Hypotension—Epirubicin—bone cancer	0.000208	0.00276	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—bone cancer	0.000207	0.00275	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000205	0.00273	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000203	0.00269	CcSEcCtD
Pimozide—Shock—Doxorubicin—bone cancer	0.000202	0.00269	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—bone cancer	0.000202	0.00268	CcSEcCtD
Pimozide—Insomnia—Epirubicin—bone cancer	0.000201	0.00267	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—bone cancer	0.000201	0.00267	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—bone cancer	0.0002	0.00266	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—bone cancer	0.000199	0.00265	CcSEcCtD
Pimozide—Somnolence—Epirubicin—bone cancer	0.000198	0.00263	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—bone cancer	0.000196	0.00261	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—bone cancer	0.000193	0.00257	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—bone cancer	0.000192	0.00256	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000192	0.00255	CcSEcCtD
Pimozide—Constipation—Epirubicin—bone cancer	0.00019	0.00253	CcSEcCtD
Pimozide—Urticaria—Methotrexate—bone cancer	0.000189	0.00251	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000187	0.00249	CcSEcCtD
Pimozide—HTR2A—hindlimb—bone cancer	0.000186	0.0517	CbGeAlD
Pimozide—Insomnia—Doxorubicin—bone cancer	0.000186	0.00247	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—bone cancer	0.000183	0.00243	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—bone cancer	0.000179	0.00238	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000178	0.00236	CcSEcCtD
Pimozide—Urticaria—Epirubicin—bone cancer	0.000177	0.00235	CcSEcCtD
Pimozide—Constipation—Doxorubicin—bone cancer	0.000176	0.00234	CcSEcCtD
Pimozide—Asthenia—Methotrexate—bone cancer	0.00017	0.00227	CcSEcCtD
Pimozide—Pruritus—Methotrexate—bone cancer	0.000168	0.00224	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—bone cancer	0.000163	0.00217	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—bone cancer	0.000163	0.00216	CcSEcCtD
Pimozide—HTR2A—appendage—bone cancer	0.00016	0.0443	CbGeAlD
Pimozide—Asthenia—Epirubicin—bone cancer	0.00016	0.00212	CcSEcCtD
Pimozide—Pruritus—Epirubicin—bone cancer	0.000157	0.00209	CcSEcCtD
Pimozide—Dizziness—Methotrexate—bone cancer	0.000157	0.00209	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—bone cancer	0.000152	0.00202	CcSEcCtD
Pimozide—Vomiting—Methotrexate—bone cancer	0.000151	0.00201	CcSEcCtD
Pimozide—Rash—Methotrexate—bone cancer	0.00015	0.00199	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—bone cancer	0.00015	0.00199	CcSEcCtD
Pimozide—Headache—Methotrexate—bone cancer	0.000149	0.00198	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—bone cancer	0.000148	0.00196	CcSEcCtD
Pimozide—Dizziness—Epirubicin—bone cancer	0.000147	0.00196	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—bone cancer	0.000146	0.00194	CcSEcCtD
Pimozide—Vomiting—Epirubicin—bone cancer	0.000141	0.00188	CcSEcCtD
Pimozide—Nausea—Methotrexate—bone cancer	0.000141	0.00188	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—bone cancer	0.000141	0.00187	CcSEcCtD
Pimozide—Rash—Epirubicin—bone cancer	0.00014	0.00186	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—bone cancer	0.00014	0.00186	CcSEcCtD
Pimozide—Headache—Epirubicin—bone cancer	0.000139	0.00185	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—bone cancer	0.000136	0.00181	CcSEcCtD
Pimozide—Nausea—Epirubicin—bone cancer	0.000132	0.00176	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—bone cancer	0.000131	0.00174	CcSEcCtD
Pimozide—Rash—Doxorubicin—bone cancer	0.00013	0.00173	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—bone cancer	0.00013	0.00172	CcSEcCtD
Pimozide—Headache—Doxorubicin—bone cancer	0.000129	0.00171	CcSEcCtD
Pimozide—Nausea—Doxorubicin—bone cancer	0.000122	0.00163	CcSEcCtD
Pimozide—CALM2—connective tissue—bone cancer	7.53e-05	0.0209	CbGeAlD
Pimozide—CALM1—connective tissue—bone cancer	7.49e-05	0.0208	CbGeAlD
Pimozide—OPRM1—spinal cord—bone cancer	6.88e-05	0.0191	CbGeAlD
Pimozide—CALM3—tendon—bone cancer	6.59e-05	0.0183	CbGeAlD
Pimozide—CALM3—bone marrow—bone cancer	6.38e-05	0.0177	CbGeAlD
Pimozide—CALM3—spinal cord—bone cancer	6.36e-05	0.0176	CbGeAlD
Pimozide—HRH1—connective tissue—bone cancer	5.47e-05	0.0152	CbGeAlD
Pimozide—CALM2—tendon—bone cancer	5.18e-05	0.0143	CbGeAlD
Pimozide—CALM1—tendon—bone cancer	5.15e-05	0.0143	CbGeAlD
Pimozide—HTR1A—spinal cord—bone cancer	5.08e-05	0.0141	CbGeAlD
Pimozide—CALM2—bone marrow—bone cancer	5.01e-05	0.0139	CbGeAlD
Pimozide—CALM2—spinal cord—bone cancer	4.99e-05	0.0138	CbGeAlD
Pimozide—CALM1—bone marrow—bone cancer	4.99e-05	0.0138	CbGeAlD
Pimozide—CALM1—spinal cord—bone cancer	4.97e-05	0.0138	CbGeAlD
Pimozide—HTR2A—connective tissue—bone cancer	4.57e-05	0.0127	CbGeAlD
Pimozide—KCNH2—bone marrow—bone cancer	4.54e-05	0.0126	CbGeAlD
Pimozide—KCNH2—spinal cord—bone cancer	4.52e-05	0.0125	CbGeAlD
Pimozide—CYP3A7—Metabolism—GSTP1—bone cancer	3.88e-05	0.000186	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—DHFR—bone cancer	3.88e-05	0.000186	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—DHFR—bone cancer	3.87e-05	0.000186	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—EGFR—bone cancer	3.86e-05	0.000185	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—EGFR—bone cancer	3.86e-05	0.000185	CbGpPWpGaD
Pimozide—CALM3—Metabolism—DHFR—bone cancer	3.85e-05	0.000185	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL3—bone cancer	3.81e-05	0.000183	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFBR2—bone cancer	3.77e-05	0.000181	CbGpPWpGaD
Pimozide—HRH1—tendon—bone cancer	3.76e-05	0.0104	CbGeAlD
Pimozide—DRD3—Signaling Pathways—TGFBR2—bone cancer	3.73e-05	0.000179	CbGpPWpGaD
Pimozide—CALM1—Metabolism—DHFR—bone cancer	3.73e-05	0.000179	CbGpPWpGaD
Pimozide—CALM2—Metabolism—DHFR—bone cancer	3.73e-05	0.000179	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—GNA11—bone cancer	3.69e-05	0.000177	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—GNA11—bone cancer	3.63e-05	0.000174	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—GNA11—bone cancer	3.62e-05	0.000174	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—GNA11—bone cancer	3.62e-05	0.000174	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—GNA11—bone cancer	3.62e-05	0.000173	CbGpPWpGaD
Pimozide—CYP2E1—tendon—bone cancer	3.61e-05	0.01	CbGeAlD
Pimozide—CALM3—Metabolism—GNA11—bone cancer	3.6e-05	0.000173	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—GNA11—bone cancer	3.56e-05	0.000171	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IGF1R—bone cancer	3.55e-05	0.00017	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IGF1R—bone cancer	3.51e-05	0.000169	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.51e-05	0.000168	CbGpPWpGaD
Pimozide—CYP2E1—spinal cord—bone cancer	3.48e-05	0.00965	CbGeAlD
Pimozide—CALM1—Metabolism—GNA11—bone cancer	3.48e-05	0.000167	CbGpPWpGaD
Pimozide—CALM2—Metabolism—GNA11—bone cancer	3.48e-05	0.000167	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ATF1—bone cancer	3.43e-05	0.000164	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ATF1—bone cancer	3.37e-05	0.000162	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ATF1—bone cancer	3.36e-05	0.000161	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL3—bone cancer	3.34e-05	0.00016	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFBR2—bone cancer	3.33e-05	0.00016	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—MDM2—bone cancer	3.33e-05	0.00016	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ATF1—bone cancer	3.31e-05	0.000159	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SMO—bone cancer	3.29e-05	0.000158	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL3—bone cancer	3.29e-05	0.000158	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CYP3A4—bone cancer	3.28e-05	0.000158	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL3—bone cancer	3.28e-05	0.000157	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CYP3A4—bone cancer	3.28e-05	0.000157	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CYP3A4—bone cancer	3.26e-05	0.000157	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFBR2—bone cancer	3.25e-05	0.000156	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL3—bone cancer	3.23e-05	0.000155	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFBR2—bone cancer	3.22e-05	0.000155	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFBR2—bone cancer	3.22e-05	0.000155	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ENO2—bone cancer	3.22e-05	0.000155	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—MDM2—bone cancer	3.22e-05	0.000155	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—MDM2—bone cancer	3.22e-05	0.000155	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—MDM2—bone cancer	3.2e-05	0.000153	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SMO—bone cancer	3.18e-05	0.000153	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SMO—bone cancer	3.18e-05	0.000153	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CYP3A4—bone cancer	3.16e-05	0.000151	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CYP3A4—bone cancer	3.16e-05	0.000151	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ENO2—bone cancer	3.15e-05	0.000151	CbGpPWpGaD
Pimozide—HTR2A—tendon—bone cancer	3.14e-05	0.0087	CbGeAlD
Pimozide—CALM2—Adaptive Immune System—MDM2—bone cancer	3.09e-05	0.000148	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—MDM2—bone cancer	3.09e-05	0.000148	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IGF1R—bone cancer	3.06e-05	0.000147	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—KIT—bone cancer	3.04e-05	0.000146	CbGpPWpGaD
Pimozide—HTR2A—spinal cord—bone cancer	3.03e-05	0.00839	CbGeAlD
Pimozide—CALM3—Signaling Pathways—GNA11—bone cancer	3.01e-05	0.000144	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KIT—bone cancer	3e-05	0.000144	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—DHFR—bone cancer	2.99e-05	0.000143	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ENO2—bone cancer	2.96e-05	0.000142	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—DHFR—bone cancer	2.92e-05	0.00014	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—GNA11—bone cancer	2.91e-05	0.00014	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—GNA11—bone cancer	2.91e-05	0.00014	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—JUN—bone cancer	2.9e-05	0.000139	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—BRAF—bone cancer	2.86e-05	0.000137	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.86e-05	0.000137	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—BRAF—bone cancer	2.82e-05	0.000135	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.81e-05	0.000135	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—GSTP1—bone cancer	2.81e-05	0.000135	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.81e-05	0.000135	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—GSTP1—bone cancer	2.8e-05	0.000134	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—JUN—bone cancer	2.8e-05	0.000134	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—JUN—bone cancer	2.8e-05	0.000134	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ATF1—bone cancer	2.8e-05	0.000134	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GNA11—bone cancer	2.8e-05	0.000134	CbGpPWpGaD
Pimozide—CALM3—Metabolism—GSTP1—bone cancer	2.79e-05	0.000134	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—EGFR—bone cancer	2.77e-05	0.000133	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.76e-05	0.000132	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—DHFR—bone cancer	2.75e-05	0.000132	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—EGFR—bone cancer	2.73e-05	0.000131	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL3—bone cancer	2.73e-05	0.000131	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GNA11—bone cancer	2.73e-05	0.000131	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ATF1—bone cancer	2.71e-05	0.00013	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ATF1—bone cancer	2.71e-05	0.00013	CbGpPWpGaD
Pimozide—CALM2—Metabolism—GSTP1—bone cancer	2.7e-05	0.00013	CbGpPWpGaD
Pimozide—CALM1—Metabolism—GSTP1—bone cancer	2.7e-05	0.00013	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IGF1R—bone cancer	2.69e-05	0.000129	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.65e-05	0.000127	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL3—bone cancer	2.64e-05	0.000127	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL3—bone cancer	2.64e-05	0.000127	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IGF1R—bone cancer	2.64e-05	0.000127	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.6e-05	0.000125	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KIT—bone cancer	2.57e-05	0.000123	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GNA11—bone cancer	2.57e-05	0.000123	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KIT—bone cancer	2.55e-05	0.000122	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CYP3A4—bone cancer	2.53e-05	0.000122	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.52e-05	0.000121	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ENO2—bone cancer	2.51e-05	0.00012	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CYP3A4—bone cancer	2.47e-05	0.000119	CbGpPWpGaD
Pimozide—CALM3—Immune System—KIT—bone cancer	2.46e-05	0.000118	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—BRAF—bone cancer	2.42e-05	0.000116	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MDM2—bone cancer	2.4e-05	0.000115	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—BRAF—bone cancer	2.4e-05	0.000115	CbGpPWpGaD
Pimozide—CALM2—Immune System—KIT—bone cancer	2.38e-05	0.000114	CbGpPWpGaD
Pimozide—CALM1—Immune System—KIT—bone cancer	2.38e-05	0.000114	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MDM2—bone cancer	2.36e-05	0.000113	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—EGFR—bone cancer	2.34e-05	0.000112	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFBR2—bone cancer	2.33e-05	0.000112	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CYP3A4—bone cancer	2.33e-05	0.000112	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—DHFR—bone cancer	2.33e-05	0.000112	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—EGFR—bone cancer	2.32e-05	0.000111	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—EGFR—bone cancer	2.28e-05	0.000109	CbGpPWpGaD
Pimozide—CALM3—Disease—KIT—bone cancer	2.27e-05	0.000109	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFBR2—bone cancer	2.26e-05	0.000108	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFBR2—bone cancer	2.26e-05	0.000108	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KIT—bone cancer	2.22e-05	0.000107	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EGFR—bone cancer	2.2e-05	0.000106	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EGFR—bone cancer	2.2e-05	0.000106	CbGpPWpGaD
Pimozide—CALM1—Disease—KIT—bone cancer	2.2e-05	0.000106	CbGpPWpGaD
Pimozide—CALM2—Disease—KIT—bone cancer	2.2e-05	0.000106	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1R—bone cancer	2.2e-05	0.000105	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—EGFR—bone cancer	2.19e-05	0.000105	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GNA11—bone cancer	2.18e-05	0.000104	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GSTP1—bone cancer	2.17e-05	0.000104	CbGpPWpGaD
Pimozide—CALM3—Disease—BRAF—bone cancer	2.14e-05	0.000103	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1R—bone cancer	2.12e-05	0.000102	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1R—bone cancer	2.12e-05	0.000102	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—bone cancer	2.12e-05	0.000102	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GSTP1—bone cancer	2.12e-05	0.000101	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—EGFR—bone cancer	2.11e-05	0.000101	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—EGFR—bone cancer	2.11e-05	0.000101	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—BRAF—bone cancer	2.09e-05	0.0001	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—JUN—bone cancer	2.08e-05	9.99e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—BRAF—bone cancer	2.07e-05	9.92e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—BRAF—bone cancer	2.07e-05	9.92e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—JUN—bone cancer	2.05e-05	9.85e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—bone cancer	2.05e-05	9.85e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—bone cancer	2.05e-05	9.85e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MMP9—bone cancer	2.03e-05	9.72e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MDM2—bone cancer	2.03e-05	9.72e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—EGFR—bone cancer	2.02e-05	9.7e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PTGS2—bone cancer	2.01e-05	9.64e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MDM2—bone cancer	2.01e-05	9.62e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MMP9—bone cancer	2e-05	9.58e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GSTP1—bone cancer	1.99e-05	9.56e-05	CbGpPWpGaD
Pimozide—ABCB1—bone marrow—bone cancer	1.99e-05	0.00552	CbGeAlD
Pimozide—ABCB1—spinal cord—bone cancer	1.98e-05	0.0055	CbGeAlD
Pimozide—CYP1A2—Metabolism—CYP3A4—bone cancer	1.97e-05	9.47e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.96e-05	9.42e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KIT—bone cancer	1.95e-05	9.35e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MDM2—bone cancer	1.94e-05	9.3e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO2—bone cancer	1.94e-05	9.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KIT—bone cancer	1.92e-05	9.2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KIT—bone cancer	1.91e-05	9.18e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KIT—bone cancer	1.88e-05	9.03e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MDM2—bone cancer	1.88e-05	9e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MDM2—bone cancer	1.88e-05	9e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—BRAF—bone cancer	1.83e-05	8.79e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—BRAF—bone cancer	1.8e-05	8.65e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—BRAF—bone cancer	1.8e-05	8.63e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—DHFR—bone cancer	1.8e-05	8.63e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MDM2—bone cancer	1.79e-05	8.59e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—bone cancer	1.78e-05	8.52e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—BRAF—bone cancer	1.77e-05	8.49e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—JUN—bone cancer	1.76e-05	8.45e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MDM2—bone cancer	1.75e-05	8.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.75e-05	8.38e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—JUN—bone cancer	1.74e-05	8.37e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—bone cancer	1.74e-05	8.37e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MDM2—bone cancer	1.73e-05	8.31e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MDM2—bone cancer	1.73e-05	8.31e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—bone cancer	1.73e-05	8.28e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.72e-05	8.23e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MMP9—bone cancer	1.71e-05	8.22e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MMP9—bone cancer	1.7e-05	8.14e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GSTP1—bone cancer	1.69e-05	8.1e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—JUN—bone cancer	1.69e-05	8.09e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GNA11—bone cancer	1.68e-05	8.06e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—bone cancer	1.67e-05	8.01e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—bone cancer	1.67e-05	8.01e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—bone cancer	1.64e-05	7.86e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—JUN—bone cancer	1.63e-05	7.82e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—JUN—bone cancer	1.63e-05	7.82e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—bone cancer	1.61e-05	7.74e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KIT—bone cancer	1.59e-05	7.64e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KIT—bone cancer	1.54e-05	7.39e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KIT—bone cancer	1.54e-05	7.39e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MDM2—bone cancer	1.54e-05	7.37e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JUN—bone cancer	1.52e-05	7.29e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MDM2—bone cancer	1.51e-05	7.25e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MDM2—bone cancer	1.51e-05	7.23e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—BRAF—bone cancer	1.5e-05	7.18e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MDM2—bone cancer	1.48e-05	7.12e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—bone cancer	1.48e-05	7.09e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—bone cancer	1.46e-05	6.98e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—bone cancer	1.45e-05	6.97e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—bone cancer	1.45e-05	6.96e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—BRAF—bone cancer	1.45e-05	6.95e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—BRAF—bone cancer	1.45e-05	6.95e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—bone cancer	1.45e-05	6.94e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—bone cancer	1.4e-05	6.73e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—bone cancer	1.4e-05	6.73e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—bone cancer	1.4e-05	6.71e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—bone cancer	1.4e-05	6.71e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—bone cancer	1.38e-05	6.64e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—bone cancer	1.38e-05	6.6e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—bone cancer	1.37e-05	6.58e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—bone cancer	1.36e-05	6.5e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JUN—bone cancer	1.33e-05	6.4e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—bone cancer	1.33e-05	6.36e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JUN—bone cancer	1.31e-05	6.3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JUN—bone cancer	1.31e-05	6.29e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTP1—bone cancer	1.3e-05	6.25e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—bone cancer	1.3e-05	6.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—bone cancer	1.29e-05	6.18e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—bone cancer	1.28e-05	6.15e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—bone cancer	1.28e-05	6.15e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—bone cancer	1.28e-05	6.13e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—bone cancer	1.27e-05	6.12e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—bone cancer	1.25e-05	6.02e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MDM2—bone cancer	1.25e-05	6.02e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—bone cancer	1.22e-05	5.87e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—bone cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—bone cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—bone cancer	1.2e-05	5.73e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—bone cancer	1.18e-05	5.68e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—bone cancer	1.18e-05	5.68e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—bone cancer	1.16e-05	5.58e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—bone cancer	1.15e-05	5.52e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—bone cancer	1.12e-05	5.39e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—bone cancer	1.1e-05	5.26e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—bone cancer	1.09e-05	5.23e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—bone cancer	1.06e-05	5.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—bone cancer	1.05e-05	5.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—bone cancer	1.05e-05	5.06e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—bone cancer	1.05e-05	5.03e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—bone cancer	1.03e-05	4.95e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—bone cancer	1.03e-05	4.95e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—bone cancer	1.03e-05	4.94e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—bone cancer	1.03e-05	4.92e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—bone cancer	1.03e-05	4.92e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—bone cancer	1.01e-05	4.86e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—bone cancer	1e-05	4.81e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—bone cancer	8.81e-06	4.23e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—bone cancer	8.75e-06	4.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—bone cancer	8.67e-06	4.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—bone cancer	8.65e-06	4.15e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—bone cancer	8.57e-06	4.11e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—bone cancer	8.51e-06	4.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—bone cancer	8.29e-06	3.98e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—bone cancer	8.29e-06	3.98e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—bone cancer	7.2e-06	3.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—bone cancer	6.96e-06	3.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—bone cancer	6.96e-06	3.34e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—bone cancer	6.75e-06	3.24e-05	CbGpPWpGaD
